The Anti-Counterfeit Authority (ACA) and the Pharmacy and Poisons Board (PPB) of Kenya have today signed a Memorandum of Understanding (MoU) in a move geared to strengthening existing collaboration in the war against counterfeit trade.
Speaking during the signing ceremony, Dr. Robi Njoroge Mbugua, Executive Director of the AntiCounterfeit Authority, emphasized that the influx of counterfeit products, including medicines,poses not only a threat to the market share of genuine products but, more critically, jeopardizes the health and safety of consumers. Dr. Mbugua reiterated that imported counterfeit products violate intellectual property rights and are strictly prohibited in the country.
Addressing the danger posed by counterfeit drugs, Dr. Fred Siyoi, CEO of the Pharmacy and
Poisons Board, highlighted the government's intensified efforts to counter the proliferation of
counterfeit drugs in the country. Dr. Siyoi underscored the board's commitment to enhancingpharmacovigilance measures to identify and eliminate dangerous products from the market.
The MoU between ACA and PPB aims to strengthen their collaborative efforts, fostering a
comprehensive approach to tackling the trade in counterfeit and illicit medicines. Key components
of the agreement include the exchange of information, collaboration in training programs, sharing of expertise, technical exchanges, and outreach activities.
Working committees will be established to implement the MoU, focusing on detailed planning and the execution of cooperative activities, Thus the two government agencies will work together to combat the pervasive trade in counterfeit and illicit medicines within the country.This collaboration is anticipated to be a landmark step forward in Kenya's fight against counterfeit and illicit trade,marking a significant stride towards ensuring the safety of consumers and protecting public health.
Data from a joint initiative by the World Customs Organization (WCO) and the International
Institute for Research Against Counterfeit Medicines (IRACM) revealed that, in 2016 alone,
customs officials across 16 countries, including Kenya, identified 113 million illicit and potentially
dangerous medicines valued at €52 million (Sh6 billion).
.
